Beijing Beilu Pharmaceutical (300016) — Net Asset Momentum
Beijing Beilu Pharmaceutical (300016) recorded a net asset momentum of 2.4% as of December 2024, with net assets of CN¥1.83 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 300016 net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Beijing Beilu Pharmaceutical Net Asset Momentum (2005–2024)
This chart tracks Beijing Beilu Pharmaceutical's year-over-year net asset growth across 20 annual reporting periods from 2005 to 2024. The most recent momentum reading is +2.4%, with net assets of CN¥1.83 Billion CNY as of December 2024. For live market cap and overall valuation, see market cap of Beijing Beilu Pharmaceutical.
Annual Net Asset History for Beijing Beilu Pharmaceutical (2005–2024)
The table below shows the complete annual net asset history for Beijing Beilu Pharmaceutical from 2005 to 2024, covering 20 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Beijing Beilu Pharmaceutical tangible equity quality to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥1.83 Billion | CN¥2.98 Billion | CN¥1.15 Billion | ▲ +2.4% |
| 2023 | CN¥1.79 Billion | CN¥2.82 Billion | CN¥1.03 Billion | ▼ -7.1% |
| 2022 | CN¥1.92 Billion | CN¥2.82 Billion | CN¥892.27 Million | ▼ -7.7% |
| 2021 | CN¥2.08 Billion | CN¥2.90 Billion | CN¥818.22 Million | ▲ +10.2% |
| 2020 | CN¥1.89 Billion | CN¥2.85 Billion | CN¥955.50 Million | ▲ +30.4% |
| 2019 | CN¥1.45 Billion | CN¥1.62 Billion | CN¥173.31 Million | ▲ +20.3% |
| 2018 | CN¥1.21 Billion | CN¥1.29 Billion | CN¥82.93 Million | ▲ +12.8% |
| 2017 | CN¥1.07 Billion | CN¥1.14 Billion | CN¥71.65 Million | ▲ +18.6% |
| 2016 | CN¥901.69 Million | CN¥956.09 Million | CN¥54.40 Million | ▼ -3.3% |
| 2015 | CN¥932.63 Million | CN¥1.05 Billion | CN¥117.39 Million | ▲ +40.0% |
| 2014 | CN¥666.33 Million | CN¥907.00 Million | CN¥240.67 Million | ▲ +19.1% |
| 2013 | CN¥559.38 Million | CN¥620.54 Million | CN¥61.16 Million | ▲ +6.8% |
| 2012 | CN¥523.96 Million | CN¥583.60 Million | CN¥59.64 Million | ▲ +6.6% |
| 2011 | CN¥491.47 Million | CN¥524.66 Million | CN¥33.19 Million | ▲ +5.1% |
| 2010 | CN¥467.62 Million | CN¥475.11 Million | CN¥7.49 Million | ▲ +7.8% |
| 2009 | CN¥433.71 Million | CN¥451.31 Million | CN¥17.60 Million | ▲ +225.5% |
| 2008 | CN¥133.23 Million | CN¥159.75 Million | CN¥26.52 Million | ▲ +47.5% |
| 2007 | CN¥90.33 Million | CN¥141.69 Million | CN¥51.36 Million | ▲ +26.2% |
| 2006 | CN¥71.59 Million | CN¥125.69 Million | CN¥54.10 Million | ▲ +10.6% |
| 2005 | CN¥64.71 Million | CN¥107.46 Million | CN¥42.75 Million | — |